The innate immune system in cystic fibrosis lung disease
about
Investigation of the pulmonary bioactivity of double-walled carbon nanotubesEffect of multi-walled carbon nanotube surface modification on bioactivity in the C57BL/6 mouse modelRhesus monkey (Macaca mulatta) mucosal antimicrobial peptides are close homologues of human moleculesCif is negatively regulated by the TetR family repressor CifRThe lactoperoxidase system links anion transport to host defense in cystic fibrosisEpithelial antimicrobial peptides in host defense against infectionSafety assessment of inhaled xylitol in mice and healthy volunteersBronchoscopic assessment of airway retention time of aerosolized xylitol.Neutrophil elastase and matrix metalloproteinase 12 in cystic fibrosis lung diseaseHuman airway epithelial cells sense Pseudomonas aeruginosa infection via recognition of flagellin by Toll-like receptor 5.Beta-D-glucoside utilization by Mycoplasma mycoides subsp. mycoides SC: possible involvement in the control of cytotoxicity towards bovine lung cells.Status of gene therapy for cystic fibrosis lung diseasePhylogenetic and metabolic diversity of bacteria associated with cystic fibrosis.Transfer of a cathelicidin peptide antibiotic gene restores bacterial killing in a cystic fibrosis xenograft modelHarnessing Neutrophil Survival Mechanisms during Chronic Infection by Pseudomonas aeruginosa: Novel Therapeutic Targets to Dampen Inflammation in Cystic FibrosisThe osmolyte xylitol reduces the salt concentration of airway surface liquid and may enhance bacterial killing.Moxifloxacin modulates inflammation during murine pneumonia.Evaluation of the ability of LL-37 to neutralise LPS in vitro and ex vivo.Aquaporin-8 expression is reduced in ileum and induced in colon of patients with ulcerative colitis.Host defence peptides: antimicrobial and immunomodulatory activity and potential applications for tackling antibiotic-resistant infections.Lack of neutrophil elastase reduces inflammation, mucus hypersecretion, and emphysema, but not mucus obstruction, in mice with cystic fibrosis-like lung disease.Elevated expression of both mRNA and protein levels of IL-17A in sputum of stable Cystic Fibrosis patients.Mucus clearance as a primary innate defense mechanism for mammalian airways.Antibiotic allergy in cystic fibrosis.Unbiased screening of marine sponge extracts for anti-inflammatory agents combined with chemical genomics identifies girolline as an inhibitor of protein synthesis.Expression and regulation of antimicrobial peptides in the gastrointestinal tract.The potential of recombinant surfactant protein D therapy to reduce inflammation in neonatal chronic lung disease, cystic fibrosis, and emphysemaSeries introduction: Innate host defense of the respiratory epithelium.Chronic Pseudomonas aeruginosa infection in cystic fibrosis airway disease: metabolic changes that unravel novel drug targets.Prevalence of streptococci and increased polymicrobial diversity associated with cystic fibrosis patient stability.In vivo airway surface liquid Cl- analysis with solid-state electrodesLow sphingosine-1-phosphate impairs lung dendritic cells in cystic fibrosisCFTR activity and mitochondrial function.Activity of antimicrobial peptides, alone or combined with conventional antibiotics, against Staphylococcus aureus isolated from the airways of cystic fibrosis patients.Antimicrobial peptides: key components of the innate immune system.Targeting cytosolic proliferating cell nuclear antigen in neutrophil-dominated inflammation.Chronic pulmonary pseudomonal infection in patients with cystic fibrosis: A model for early phase symbiotic evolution.The Role of Human Beta-Defensin-2 in Pseudomonas aeruginosa Pulmonary Infection in Cystic Fibrosis Patients.Mucin glycosylation changes in cystic fibrosis lung disease are not manifest in submucosal gland secretionsClinical implications of Pseudomonas aeruginosa location in the lungs of patients with cystic fibrosis.
P2860
Q23922850-6A2BA841-AB0D-44C8-9DAC-D31EDA479C96Q23922858-48FEEE62-333B-4A8A-8914-8BACF3FB8E25Q24548852-64E119D0-229D-4B0D-9927-CCBC56FC1532Q24646990-5F87092B-5215-4F33-B8A0-46A66EC3A765Q24683917-364C1391-637B-4F59-9102-5AC2CB37F720Q24791605-1DE51155-DE92-48A6-8128-BDC230FDFE26Q24799101-11255FB3-0FD5-4E1A-B72E-73CE739DC0C7Q25255838-B929C738-BCFB-4692-BB1F-D64F3F56ABD5Q26741691-AACE4442-B4EF-4724-AA2F-DCD0B91C1F13Q30447044-CB0C7A28-6E9A-4FA4-A4FB-21005234E937Q33282318-DCC25D93-A507-43F9-B1BA-86CEFCF50163Q33533855-52897698-B27A-4D40-B0A9-2BAC77986B43Q33633034-38A0DB34-6404-4898-9F61-48105110587CQ33849677-59883A98-0D0B-447F-8175-F4CC8FEE6866Q33857503-6B0DAFB7-B55C-47F8-BB68-7789000B7D08Q33920973-DBA0B886-9FD9-412E-94F8-6F3903DFD3D9Q33986123-91245676-EC2E-4F7F-9ED1-300237AAF337Q34058642-CA317A9A-956B-41F3-B2EE-19F3821380D7Q34099352-D659C2BF-1E80-440E-902F-123DD313AF04Q34264486-15CFFC6F-3466-4152-9CAA-28761F4413ABQ34412599-E7553441-553E-481B-9060-5DEACF9C2495Q34481869-850196BA-FD04-4FF4-A133-0F0032943046Q34551378-F38F26D0-615B-4CF2-8684-3F697A59735AQ34558027-062AD483-80A0-4556-8140-E370548D8C07Q35211600-E9354C19-D54C-489F-B123-EC49D177E81EQ35550003-1468BF15-0805-408B-8674-8882C96CA3C0Q35581614-DCA9B04E-8FBF-4426-AF32-59A3B11D2087Q35581626-3B905989-B2F4-4CBB-B688-ADF50BFDC2D7Q35917498-BB09EB76-333D-47E5-97E8-A2C884D6B513Q36152854-AFA0CE07-ECC5-49ED-902D-A12ACA5DDC01Q36445272-EE1D19D1-1409-4801-BB8E-E6FF2CC9F2CDQ36703926-4C9D7C30-6EAC-4640-AB93-650FE9291F38Q37133567-634F0B0A-9FE9-429E-A81E-1D3B0E4592C8Q37705410-1F44858F-B2F6-4C46-9BF9-B87625A0A2F6Q37954721-63E5AA79-6D73-439C-9C39-ABB5F32B2182Q38062530-CCC67F73-CDCE-4512-8F05-EC3C2324670DQ38207078-1F9514DD-7F0E-4591-8A06-A440D713B2A9Q38240975-0F795560-6AC0-41C6-BFB3-204C6E6DE2A6Q38333894-F37C885A-CE4F-4A5D-AA37-EA6E710962EFQ39218303-F2A5DCBF-F48F-4545-9289-E3EA8BC35E9E
P2860
The innate immune system in cystic fibrosis lung disease
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
The innate immune system in cystic fibrosis lung disease
@en
type
label
The innate immune system in cystic fibrosis lung disease
@en
prefLabel
The innate immune system in cystic fibrosis lung disease
@en
P2860
P356
P1476
The innate immune system in cystic fibrosis lung disease
@en
P2093
P2860
P304
P356
10.1172/JCI6277
P407
P577
1999-02-01T00:00:00Z